Sunshine Biopharma Financial Overview
Sunshine Biopharma's market cap is currently $6.82M. The company's EPS TTM is $-0.19; its P/E ratio is -0.73; Sunshine Biopharma is scheduled to report earnings on November 11, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
